FDA invests in clinical trial data

Share this article:

The FDA is putting up to $37.5 million toward improving clinical trials. Regulatory Focus reports that the regulator announced the money will go toward the Clinical Trials Transformation Initiative based at Duke University.

RF notes that the site is of note because the CTTI “includes nearly every government healthcare agency, pharmaceutical company and trade group as members, as well as several medical device manufacturers.”

RF says the goal of the multi-million-dollar effort is to improve data-driven decision-making.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.